Ayurvedic Concepts GastriCare and Prostacare G-I, prostate claims are drug claims -- FDA.
This article was originally published in The Tan Sheet
Executive Summary
GASTRICARE AND PROSTACARE G-I, PROSTATE CLAIMS CITED BY FDA as unapproved drug claims in a Jan. 6 "courtesy letter" to Houston, Tex.-based Ayurvedic Concepts. The Dietary Supplement Health & Education Act of 1994 "makes clear that a statement included in labeling...may not claim to diagnose, mitigate, treat, cure or prevent a specific disease or class of diseases," the letter states. "The statements that you are making for these products suggest that they are intended to treat or mitigate disease," FDA told the company.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning